World Bank cuts India's growth forecast for FY22 to 8.3%
Darpan News Desk IANS, 08 Jun, 2021 04:20 PM
New Delhi, June 8 (IANS) The World Bank has lowered the growth projection for India for the financial year 2021-22 to 8.3 per cent. Its previous growth estimate for the fiscal was 10.1 per cent.
"In South Asia, India's recovery is being hampered by the largest outbreak of any country since the beginning of the pandemic," said the World Bank's global outlook released on Tuesday.
The global economy, on the other hand is set to expand 5.6 per cent in 2021, its strongest post-recession pace in 80 years.
"This recovery is uneven and largely reflects sharp rebounds in some major economies -most notably the United States, owing to substantial fiscal support, amid highly unequal vaccine access," it said.
In many emerging market and developing economies (EMDEs), elevated Covid-19 caseloads, obstacles to vaccination, and a partial withdrawal of macroeconomic support are offsetting some of the benefits of strengthening external demand and elevated commodity prices, the report noted.
Globally, it also noted that following a 3.5 per cent contraction caused by the Covid-19 pandemic in 2020, economic activity has gained significant momentum. However, it remains well below pre-pandemic projections.
Moreover, the recovery is uneven, passing over many poorer countries, and there is considerable uncertainty about its durability, it added.
Rajan Palakkundu Parambil, a 53-year-old worker from Malappuram in Kerala, was employed by a contracting company in Najran, a Saudi city that shares a border with Yemen, the Saudi Gazette reported.
Simone Burns, an Irish lawyer, spat at a flight attendant during her foul-mouthed racist tirade after she was refused alcohol on the flight in November last year.
The Special Investigation Team (SIT) formed by the Punjab Government to probe the Neha Shoree murder case has found the name and number of the killer saved on her phone.
An Indian journal publisher and his companies have been fined over USD 50 million in the US for making “deceptive claims” to academics about the nature of their work and taking millions of dollars from aspiring researchers and writers.
The Bench, also comprising Justices Deepak Gupta and Sanjiv Khanna, has now fixed the contempt petition of the Japanese firms against the former Ranbaxy promoters for hearing on April 11.
